Research outputs

  1. 2019
  2. ALK phosphorylates SMAD4 on tyrosine to disable TGF-β tumour suppressor functions

    Zhang, Q., Xiao, M., Gu, S., Xu, Y., Liu, T., Li, H., Yu, Y., Qin, L., Zhu, Y., Chen, F., Wang, Y., Ding, C., Wu, H., Ji, H., Chen, Z., Zu, Y., Malkoski, S., Li, Y., Liang, T., Ji, J. & 6 othersQin, J., Xu, P., Zhao, B., Shen, L., Lin, X. & Feng, X. H., Feb 1 2019, In : Nature Cell Biology. 21, 2, p. 179-189 11 p.

    Research output: Contribution to journalArticle

  3. Aptamer-Engineered Natural Killer Cells for Cell-Specific Adaptive Immunotherapy

    Yang, S., Wen, J., Li, H., Xu, L., Liu, Y., Zhao, N., Zeng, Z., Qi, J., Jiang, W., Han, W. & Zu, Y., Jan 1 2019, In : Small. 1900903.

    Research output: Contribution to journalArticle

  4. 2018
  5. Oligonucleotide Aptamer-Mediated Precision Therapy of Hematological Malignancies

    Yang, S., Li, H., Xu, L., Deng, Z., Han, W., Liu, Y., Jiang, W. & Zu, Y., Dec 7 2018, In : Molecular Therapy - Nucleic Acids. 13, p. 164-175 12 p.

    Research output: Contribution to journalReview article

  6. Clinical Significance of PTEN Deletion, Mutation, and Loss of PTEN Expression in De Novo Diffuse Large B-Cell Lymphoma

    Wang, X., Cao, X., Sun, R., Tang, C., Tzankov, A., Zhang, J., Manyam, G. C., Xiao, M., Miao, Y., Jabbar, K., Tan, X., Pang, Y., Visco, C., Xie, Y., Dybkaer, K., Chiu, A., Orazi, A., Zu, Y., Bhagat, G., Richards, K. L. & 16 othersHsi, E. D., Choi, W. W. L., van Krieken, J. H., Huh, J., Ponzoni, M., Ferreri, A. J. M., Møller, M. B., Parsons, B. M., Winter, J. N., Piris, M. A., Li, S., Miranda, R. N., Medeiros, L. J., Li, Y., Xu-Monette, Z. Y. & Young, K. H., Jun 1 2018, In : Neoplasia (United States). 20, 6, p. 574-593 20 p.

    Research output: Contribution to journalArticle

  7. DNA Thioaptamer with Homing Specificity to Lymphoma Bone Marrow Involvement

    Mai, J., Li, X., Zhang, G., Huang, Y., Xu, R., Shen, Q., Lokesh, G. L., Thiviyanathan, V., Chen, L., Liu, H., Zu, Y., Ma, X., Volk, D. E., Gorenstein, D. G., Ferrari, M. & Shen, H., May 7 2018, In : Molecular Pharmaceutics. 15, 5, p. 1814-1825 12 p.

    Research output: Contribution to journalArticle

  8. Tumor-specific t-cells engineered to overcome tumor immune evasion induce clinical responses in patients with relapsed hodgkin lymphoma

    Bollard, C. M., Tripic, T., Cruz, C. R., Dotti, G., Gottschalk, S., Torrano, V., Dakhova, O., Carrum, G., Ramos, C. A., Liu, H., Wu, M. F., Marcogliese, A. N., Barese, C., Zu, Y., Lee, D. Y., O’Connor, O., Gee, A. P., Brenner, M., Heslop, H. & Rooney, C. M., Apr 10 2018, In : Journal of Clinical Oncology. 36, 11, p. 1128-1139 12 p.

    Research output: Contribution to journalArticle

  9. A novel DNA aptamer for dual targeting of polymorphonuclear myeloid-derived suppressor cells and tumor cells

    Liu, H., Mai, J., Shen, J., Wolfram, J., Li, Z., Zhang, G., Xu, R., Li, Y., Mu, C., Zu, Y., Li, X., Lokesh, G. L., Thiviyanathan, V., Volk, D. E., Gorenstein, D. G., Ferrari, M., Hu, Z. & Shen, H., 2018, In : Theranostics. 8, 1, p. 31-44 14 p.

    Research output: Contribution to journalArticle

  10. Updates in Polycythemia Vera

    Nagrale, V., Olsen, R. J. & Zu, Y., 2018, Precision Molecular Pathology of Myeloid Neoplasms. Chang, C-C. J. & Ohgami, R. (eds.). 1st ed. Switzerland: Springer, Vol. 12. p. 115-139

    Research output: Chapter in Book/Report/Conference proceedingChapter (peer-reviewed)

  11. 2017
  12. Spin-Valve based magnetoresistive nanoparticle detector for applications in biosensing

    Qiu, W., Chang, L., Liang, Y. C., Litvinov, J., Guo, J., Chen, Y. T., Vu, B., Kourentzi, K., Xu, S., Lee, T. R., Zu, Y., Willson, R. C. & Litvinov, D., Oct 1 2017, In : Sensors and Actuators, A: Physical. 265, p. 174-180 7 p.

    Research output: Contribution to journalArticle

  13. Diagnostic algorithm of common mature B-cell lymphomas by immunohistochemistry

    Wang, H. Y. & Zu, Y., Sep 1 2017, In : Archives of Pathology and Laboratory Medicine. 141, 9, p. 1236-1246 11 p.

    Research output: Contribution to journalArticle

  14. Cellular function reinstitution of offspring red blood cells cloned from the sickle cell disease patient blood post CRISPR genome editing

    Wen, J., Tao, W., Hao, S. & Zu, Y., Jun 13 2017, In : Journal of Hematology and Oncology. 10, 1, 119.

    Research output: Contribution to journalArticle

  15. Ultrasensitive magnetic nanoparticle detector for biosensor applications

    Liang, Y. C., Chang, L., Qiu, W., Kolhatkar, A. G., Vu, B., Kourentzi, K., Lee, T. R., Zu, Y., Willson, R. C. & Litvinov, D., Jun 6 2017, In : Sensors (Switzerland). 17, 6, 1296.

    Research output: Contribution to journalArticle

  16. Aptamer internalization via endocytosis inducing s-phase arrest and priming maver-1 lymphoma cells for cytarabine chemotherapy

    Li, H., Yang, S., Yu, G., Shen, L., Fan, J., Xu, L., Zhang, H., Zhao, N., Zeng, Z., Hu, T., Wen, J. & Zu, Y., 2017, In : Theranostics. 7, 5, p. 1204-1213 10 p.

    Research output: Contribution to journalArticle

  17. Self-Assembled Aptamer-Nanomedicine for Targeted Chemotherapy and Gene Therapy

    Zhao, N., Zeng, Z. & Zu, Y., 2017, (Accepted/In press) In : Small.

    Research output: Contribution to journalArticle

  18. 2016
  19. Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma

    Xu-Monette, Z. Y., Li, L., Byrd, J. C., Jabbar, K. J., Manyam, G. C., De Winde, C. M., Van Den Brand, M., Tzankov, A., Visco, C., Wang, J., Dybkaer, K., Chiu, A., Orazi, A., Zu, Y., Bhagat, G., Richards, K. L., Hsi, E. D., Choi, W. W. L., Huh, J., Ponzoni, M. & 12 othersFerreri, A. J. M., Møller, M. B., Parsons, B. M., Winter, J. N., Wang, M., Hagemeister, F. B., Piris, M. A., Van Krieken, J. H., Medeiros, L. J., Li, Y., Van Spriel, A. B. & Young, K. H., Dec 29 2016, In : Blood. 128, 26, p. 3083-3100 18 p.

    Research output: Contribution to journalArticle

  20. B7-H4 expression in ovarian serous carcinoma: a study of 306 cases

    Liang, L., Jiang, Y., Chen, J. S., Niu, N., Piao, J., Ning, J., Zu, Y., Zhang, J. & Liu, J., Nov 1 2016, In : Human pathology. 57, p. 1-6 6 p.

    Research output: Contribution to journalArticle

  21. Loss of PRDM1/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphoma

    Xia, Y., Xu-Monette, Z. Y., Tzankov, A., Li, X., Manyam, G. C., Murty, V., Bhagat, G., Zhang, S., Pasqualucci, L., Visco, C., Dybkaer, K., Chiu, A., Orazi, A., Zu, Y., Richards, K. L., Hsi, E. D., Choi, W. W. L., van Krieken, J. H., Huh, J., Ponzoni, M. & 13 othersFerreri, A. J. M., Møller, M. B., Parsons, B. M., Winter, J. N., Piris, M. A., Westin, J., Fowler, N., Miranda, R. N., Ok, C. Y., Li, Y., Li, J., Medeiros, L. J. & Young, K. H., Sep 30 2016, (Accepted/In press) In : Leukemia.

    Research output: Contribution to journalArticle

  22. Cytogenetic landscape and impact in blast phase of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy

    Chen, Z., Shao, C., Wang, W., Zuo, Z., Mou, X., Hu, S. J., DiGiuseppe, J. A., Zu, Y., Medeiros, L. J. & Hu, S., Sep 2 2016, (Accepted/In press) In : Leukemia.

    Research output: Contribution to journalArticle

  23. Overt leukemic phase: an unusual presentation of angioimmunoblastic lymphoma

    Arora, K., Zhang, L., Xie, W., Baker, K. R., Zu, Y. & Hao, S., Sep 1 2016, In : Journal of Hematopathology. 9, 3, p. 139-142 4 p.

    Research output: Contribution to journalArticle

  24. Clinical and biologic significance of MYC genetic mutations in de novo diffuse large B-cell lymphoma

    Xu-Monette, Z. Y., Deng, Q., Manyam, G. C., Tzankov, A., Li, L., Xia, Y., Wang, X. X., Zou, D., Visco, C., Dybkær, K., Li, J., Zhang, L., Liang, H., Montes-Moreno, S., Chiu, A., Orazi, A., Zu, Y., Bhagat, G., Richards, K. L., Hsi, E. D. & 14 othersChoi, W. W. L., Van Krieken, J. H., Huh, J., Ponzoni, M., Ferreri, A. J. M., Parsons, B. M., Møller, M. B., Wang, S. A., Miranda, R. N., Piris, M. A., Winter, J. N., Medeiros, L. J., Li, Y. & Young, K. H., Jul 15 2016, In : Clinical Cancer Research. 22, 14, p. 3593-3605 13 p.

    Research output: Contribution to journalArticle

  25. A unique aptamer-drug conjugate for targeted therapy of multiple myeloma

    Wen, J., Tao, W., Hao, S., Iyer, S. P. & Zu, Y., Apr 2016, In : Leukemia. 30, 4, p. 987-91 5 p.

    Research output: Contribution to journalArticle

  26. Aptamers: Versatile molecular recognition probes for cancer detection

    Sun, H., Tan, W. & Zu, Y., Jan 21 2016, In : Analyst. 141, 2, p. 403-415 13 p.

    Research output: Contribution to journalArticle

  27. SsDNA aptamer specifically targets and selectively delivers cytotoxic drug doxorubicin to HepG2 Cells

    Yu, G., Li, H., Yang, S., Wen, J., Niu, J. & Zu, Y., Jan 1 2016, In : PLoS ONE. 11, 1, e0147674.

    Research output: Contribution to journalArticle

  28. p63 expression confers significantly better survival outcomes in highrisk diffuse large B-cell lymphoma and demonstrates p53-like and p53-independent tumor suppressor function

    Xu-Monette, Z. Y., Zhang, S., Li, X., Manyam, G. C., Wang, X. X., Xia, Y., Visco, C., Tzankov, A., Zhang, L., Montes-Moreno, S., Dybkaer, K., Chiu, A., Orazi, A., Zu, Y., Bhagat, G., Richards, K. L., Hsi, E. D., Choi, W. W. L., Van Krieken, H. J., Huh, J. & 9 othersPonzoni, M., Ferreri, A. J. M., Zhao, X., Møller, M. B., Parsons, B. M., Winter, J. N., Piris, M. A., Medeiros, J. L. & Young, K. H., 2016, In : Aging. 8, 2, p. 345-365 21 p.

    Research output: Contribution to journalArticle

  29. Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma

    Ye, Q., Xu-Monette, Z. Y., Tzankov, A., Deng, L., Wang, X., Manyam, G. C., Visco, C., Montes-Moreno, S., Zhang, L., Dybkær, K., Chiu, A., Orazi, A., Zu, Y., Bhagat, G., Richards, K. L., Hsi, E. D., Choi, W. W. L., van Krieken, J. H., Huh, J., Ponzoni, M. & 8 othersFerreri, A. J. M., Parsons, B. M., Møller, M. B., Piris, M. A., Winter, J. N., Medeiros, L. J., Hu, V. D. S. & Young, K. H., 2016, In : Oncotarget. 7, 3, p. 2401-2416 16 p.

    Research output: Contribution to journalArticle

  30. RelA NF-kB subunit activation as a therapeutic target in diffuse large B-cell lymphoma

    Zhang, M., Xu-Monette, Z. Y., Li, L., Manyam, G. C., Visco, C., Tzankov, A., Wang, J., Montes-Moreno, S., Dybkaer, K., Chiu, A., Orazi, A., Zu, Y., Bhagat, G., Richards, K. L., Hsi, E. D., Choi, W. W. L., van Krieken, J. H., Huh, J., Ponzoni, M., Ferreri, A. J. M. & 7 othersMøller, M. B., Parsons, B. M., Winter, J. N., Piris, M. A., Medeiros, L. J., Pham, L. V. & Young, K. H., 2016, In : Aging. 8, 12, p. 3321-3340 20 p.

    Research output: Contribution to journalArticle

  31. 2015
  32. Clinical features, tumor biology, and prognosis associated with MYC rearrangement and Myc overexpression in diffuse large B-cell lymphoma patients treated with rituximab-CHOP

    Xu-Monette, Z. Y., Dabaja, B. S., Wang, X., Tu, M., Manyam, G. C., Tzankov, A., Xia, Y., Zhang, L., Sun, R., Visco, C., Dybkaer, K., Yin, L., Chiu, A., Orazi, A., Zu, Y., Bhagat, G., Richards, K. L., Hsi, E. D., Choi, W. W. L., Van Krieken, J. H. & 13 othersHuh, J., Ponzoni, M., Ferreri, A. J. M., Møller, M. B., Parsons, B. M., Zhao, X., Winter, J. N., Piris, M. A., McDonnell, T. J., Miranda, R. N., Li, Y., Medeiros, L. J. & Young, K. H., Dec 1 2015, In : Modern Pathology. 28, 12, p. 1555-1573 19 p.

    Research output: Contribution to journalArticle

  33. Prognostic and biological significance of survivin expression in patients with diffuse large B-cell lymphoma treated with rituximab-CHOP therapy

    Liu, Z., Xu-Monette, Z. Y., Cao, X., Manyam, G. C., Wang, X., Tzankov, A., Xia, Y., Li, X., Visco, C., Sun, R., Zhang, L., Montes-Moreno, S., Dybkær, K., Chiu, A., Orazi, A., Zu, Y., Bhagat, G., Richards, K. L., Hsi, E. D., Choi, W. W. L. & 11 othersVan Krieken, J. H., Huh, J., Ponzoni, M., Ferreri, A. J. M., Parsons, B. M., Møller, M. B., Piris, M. A., Winter, J. N., O'Malley, D. P., Medeiros, L. J. & Young, K. H., Oct 3 2015, In : Modern Pathology. 28, 10, p. 1297-1314 18 p.

    Research output: Contribution to journalArticle

  34. Oligonucleotide aptamer-drug conjugates for targeted therapy of acute myeloid leukemia

    Zhao, N., Pei, S. N., Qi, J., Zeng, Z., Iyer, S. P., Lin, P., Tung, C. H. & Zu, Y., Oct 1 2015, In : Biomaterials. 67, p. 42-51 10 p.

    Research output: Contribution to journalArticle

  35. Evaluation of NF-κB subunit expression and signaling pathway activation demonstrates that p52 expression confers better outcome in germinal center B-cell-like diffuse large B-cell lymphoma in association with CD30 and BCL2 functions

    Ok, C. Y., Xu-Monette, Z. Y., Li, L., Manyam, G. C., Montes-Moreno, S., Tzankov, A., Visco, C., Dybkær, K., Routbort, M. J., Zhang, L., Chiu, A., Orazi, A., Zu, Y., Bhagat, G., Richards, K. L., Hsi, E. D., Choi, W. W. L., Van Krieken, J. H., Huh, J., Ponzoni, M. & 9 othersFerreri, A. J. M., Parsons, B. M., Rao, H., Møller, M. B., Winter, J. N., Piris, M. A., Wang, S. A., Medeiros, L. J. & Young, K. H., Sep 3 2015, In : Modern Pathology. 28, 9, p. 1202-1213 12 p.

    Research output: Contribution to journalArticle

  36. CRISPR-Cas9 delivery to hard-to-transfect cells via membrane deformation

    Han, X., Liu, Z., Jo, M. C., Zhang, K., Li, Y., Zeng, Z., Li, N., Zu, Y. & Qin, L., Aug 1 2015, In : Science Advances. 1, 7, p. e1500454 e1500454.

    Research output: Contribution to journalArticle

  37. A Highlight of recent advances in aptamer technology and its application

    Sun, H. & Zu, Y., Jul 1 2015, In : Molecules. 20, 7, p. 11959-11980 22 p.

    Research output: Contribution to journalArticle

  38. Pre-clinical efficacy of combined therapy with novel β-catenin antagonist BC2059 and histone deacetylase inhibitor against AML cells

    Fiskus, W., Sharma, S., Saha, S., Shah, B., Devaraj, S. G. T., Sun, B., Horrigan, S., Leveque, C., Zu, Y., Iyer, S. & Bhalla, K. N., Jun 9 2015, In : Leukemia. 29, 6, p. 1267-1278 12 p.

    Research output: Contribution to journalArticle

  39. Aptamers and their applications in nanomedicine

    Sun, H. & Zu, Y., May 27 2015, In : Small. 11, 20, p. 2352-2364 13 p.

    Research output: Contribution to journalArticle

  40. Mutated genes and driver pathways involved in myelodysplastic syndromes - a transcriptome sequencing based approach

    Liu, L., Wang, H., Wen, J., Tseng, C. E., Zu, Y., Chang, C. C. & Zhou, X., May 14 2015, In : Molecular BioSystems. 11, 8, p. 2158-2166 9 p.

    Research output: Contribution to journalArticle

  41. Dynamic balance of multiple myeloma clonogenic side population cell percentages controlled by environmental conditions

    Wen, J., Tao, W., Kuiatse, I., Lin, P., Feng, Y., Jones, R. J., Orlowski, R. Z. & Zu, Y., Jan 1 2015, In : International Journal of Cancer. 136, 5, p. 991-1002 12 p.

    Research output: Contribution to journalArticle

  42. SDF-1α stiffens myeloma Bone marrow mesenchymal stromal cells through the activation of RhoA-ROCK-Myosin II

    Choi, D. S., Stark, D. J., Raphael, R. M., Wen, J., Su, J., Zhou, X., Chang, C. C. & Zu, Y., Jan 1 2015, In : International Journal of Cancer. 136, 5, p. E219-E229

    Research output: Contribution to journalArticle

  43. Age cutoff for Epstein-Barr virus-positive diffuse large B-cell lymphoma-is it necessary?

    Ok, C. Y., Ye, Q., Li, L., Manyam, G. C., Deng, L., Goswami, R. R., Wang, X., Montes-Moreno, S., Visco, C., Tzankov, A., Dybkaer, K., Zhang, L., Abramson, J., Sohani, A. R., Chiu, A., Orazi, A., Zu, Y., Bhagat, G., Richards, K. L., Hsi, E. D. & 14 othersChoi, W. W. L., van Krieken, J. H., Huh, J., Ponzoni, M., Ferreri, A. J. M., Zhang, S., Parsons, B. M., Xu, M., Møller, M. B., Winter, J. N., Piris, M. A., Xu-Monette, Z. Y., Medeiros, L. J. & Young, K. H., 2015, In : Oncotarget. 6, 16, p. 13933-13945 13 p.

    Research output: Contribution to journalArticle

  44. Clinical and biological significance of de novo CD5+ diffuse large B-cell lymphoma in Western countries

    Xu-Monette, Z. Y., Tu, M., Jabbar, K. J., Cao, X., Tzankov, A., Visco, C., Cai, Q., Montes-Moreno, S., An, Y., Dybkaer, K., Chiu, A., Orazi, A., Zu, Y., Bhagat, G., Richards, K. L., Hsi, E. D., Choi, W. W. L., Van Krieken, J. H., Huh, J., Ponzoni, M. & 9 othersFerreri, A. J. M., Zhao, X., Møller, M. B., Farnen, J. P., Winter, J. N., Piris, M. A., Miranda, R. N., Medeiros, L. J. & Young, K. H., 2015, In : Oncotarget. 6, 8, p. 5615-5633 19 p.

    Research output: Contribution to journalArticle

  45. Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphoma

    Chen, J., Xu-Monette, Z. Y., Deng, L., Shen, Q., Manyam, G. C., Martinez-Lopez, A., Zhang, L., Montes-Moreno, S., Visco, C., Tzankov, A., Yin, L., Dybkaer, K., Chiu, A., Orazi, A., Zu, Y., Bhagat, G., Richards, K. L., Hsi, E. D., Choi, W. W. L., Han van Krieken, J. & 10 othersHuh, J., Ponzoni, M., Ferreri, A. J. M., Zhao, X., Møller, M. B., Farnen, J. P., Winter, J. N., Piris, M. A., Pham, L. & Young, K. H., 2015, In : Oncotarget. 6, 8, p. 5597-5614 18 p.

    Research output: Contribution to journalArticle

  46. Erratum to Clinical and biological significance of de novo CD5+ diffuse large B-cell lymphoma in Western countries [Oncotarget, 8, (2015), 5615-5633]

    Xu-Monette, Z. Y., Tu, M., Jabbar, K. J., Cao, X., Tzankov, A., Visco, C., Nagarajan, L., Cai, Q., Montes-Moreno, S., An, Y., Dybkaer, K., Chiu, A., Orazi, A., Zu, Y., Bhagat, G., Richards, K. L., Hsi, E. D., Choi, W. W. L., van Krieken, J. H., Huh, J. & 10 othersPonzoni, M., Ferreri, A. J. M., Zhao, X., Møller, M. B., Farnen, J. P., Winter, J. N., Piris, M. A., Miranda, R. N., Medeiros, L. J. & Young, K. H., 2015, In : Oncotarget. 6, 16, p. 14720 1 p.

    Research output: Contribution to journalArticle

  47. Prognostic impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphoma

    Li, L., Xu-Monette, Z. Y., Ok, C. Y., Tzankov, A., Manyam, G. C., Sun, R., Visco, C., Zhang, M., Montes-Moreno, S., Dybkaer, K., Chiu, A., Orazi, A., Zu, Y., Bhagat, G., Richards, K. L., Hsi, E. D., Choi, W. W. L., van Krieken, J. H., Huh, J., Ponzoni, M. & 9 othersFerreri, A. J. M., Møller, M. B., Wang, J., Parsons, B. M., Winter, J. N., Piris, M. A., Pham, L. V., Jeffrey Medeiros, L. & Young, K. H., 2015, In : Oncotarget. 6, 27, p. 23157-23180 24 p.

    Research output: Contribution to journalArticle

  48. 2014
  49. Clinical implications of phosphorylated STAT3 expression in de Novo diffuse large B-cell lymphoma

    Ok, C. Y., Chen, J., Xu-Monette, Z. Y., Tzankov, A., Manyam, G. C., Li, L., Visco, C., Montes-Moreno, S., Dybkær, K., Chiu, A., Orazi, A., Zu, Y., Bhagat, G., Richards, K. L., Hsi, E. D., Choi, W. W. L., Van Krieken, J. H., Huh, J., Zhao, X., Ponzoni, M. & 8 othersFerreri, A. J. M., Bertoni, F., Farnen, J. P., Møller, M. B., Piris, M. A., Winter, J. N., Medeiros, L. J. & Young, K. H., Oct 1 2014, In : Clinical Cancer Research. 20, 19, p. 5113-5123 11 p.

    Research output: Contribution to journalArticle

  50. Hand-held and integrated single-cell pipettes

    Zhang, K., Han, X., Li, Y., Li, S. Y., Zu, Y., Wang, Z. & Qin, L., Aug 6 2014, In : Journal of the American Chemical Society. 136, 31, p. 10858-10861 4 p.

    Research output: Contribution to journalArticle

  51. Oligonucleotide aptamers: New tools for targeted cancer therapy

    Sun, H., Zhu, X., Lu, P. Y., Rosato, R. R., Tan, W. & Zu, Y., Aug 5 2014, In : Molecular Therapy - Nucleic Acids. 3, e182.

    Research output: Contribution to journalArticle

  52. Specific and sensitive tumor imaging using biostable oligonucleotide aptamer probes

    Zeng, Z., Parekh, P., Li, Z., Shi, Z-Z., Tung, C-H. & Zu, Y., Jul 19 2014, In : Theranostics. 4, 9, p. 945-52 8 p.

    Research output: Contribution to journalArticle

  53. Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: A report from the International DLBCL Rituximab-CHOP Consortium Program

    Ok, C. Y., Xu-Monette, Z. Y., Tzankov, A., O'Malley, D. P., Montes-Moreno, S., Visco, C., Møller, M. B., Dybkær, K., Orazi, A., Zu, Y., Bhagat, G., Richards, K. L., Hsi, E. D., Han Van Krieken, J., Ponzoni, M., Farnen, J. P., Piris, M. A., Winter, J. N., Medeiros, L. J. & Young, K. H., Jun 15 2014, In : Cancer. 120, 12, p. 1818-1829 12 p.

    Research output: Contribution to journalArticle

  54. A cancer cell-activatable aptamer-reporter system for one-step assay of circulating tumor cells

    Zeng, Z., Tung, C. H. & Zu, Y., May 8 2014, In : Molecular Therapy - Nucleic Acids. 3, e184.

    Research output: Contribution to journalArticle

  55. Prevalence and clinical implications of Epstein-Barr virus infection in de Novo diffuse large B-cell lymphoma in western countries

    Ok, C. Y., Li, L., Xu-Monette, Z. Y., Visco, C., Tzankov, A., Manyam, G. C., Montes-Moreno, S., Dybaer, K., Chiu, A., Orazi, A., Zu, Y., Bhagat, G., Chen, J., Richards, K. L., Hsi, E. D., Choi, W. W. L., Van Krieken, J. H., Huh, J., Ai, W., Ponzoni, M. & 9 othersFerreri, A. J. M., Farnen, J. P., Møller, M. B., Bueso-Ramos, C. E., Miranda, R. N., Winter, J. N., Piris, M. A., Medeiros, L. J. & Young, K. H., May 1 2014, In : Clinical Cancer Research. 20, 9, p. 2338-2349 12 p.

    Research output: Contribution to journalArticle

  56. Enteropathy-associated T-cell lymphoma, type II (monomorphic variant)

    Raza, A. & Zu, Y., Apr 3 2014, In : Blood. 123, 14

    Research output: Contribution to journalArticle

Previous 1 2 3 Next

ID: 2285879